Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Raquel Perez‐Lopez"'
Autor:
Marta Ligero, Bente Gielen, Victor Navarro, Pablo Cresta Morgado, Olivia Prior, Rodrigo Dienstmann, Paolo Nuciforo, Stefano Trebeschi, Regina Beets-Tan, Evis Sala, Elena Garralda, Raquel Perez-Lopez
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-9 (2024)
Abstract The search for understanding immunotherapy response has sparked interest in diverse areas of oncology, with artificial intelligence (AI) and radiomics emerging as promising tools, capable of gathering large amounts of information to identify
Externí odkaz:
https://doaj.org/article/49b9928b68a74233b3c504afa90ca7b9
Autor:
Francesca Zacchi, Joan Carles, Macarena Gonzalez, Xavier Maldonado, Raquel Perez-Lopez, Maria Eugenia Semidey, Joaquin Mateo
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Despite the development of new therapies in the last few years, metastatic prostate cancer (PCa) is still a lethal disease. Radium-223 (Ra-223) is approved for patients with advanced castration-resistant prostate cancer (CRPC) with bone metastases an
Externí odkaz:
https://doaj.org/article/ecf8b1bc8e794feba090feadba35f493
Autor:
Marta Ligero, Marc Simó, Cecilia Carpio, Gloria Iacoboni, Maria Balaguer‐Montero, Victor Navarro, Mario Andres Sánchez‐Salinas, Sabela Bobillo, Ana Marín‐Niebla, Josu Iraola‐Truchuelo, Pau Abrisqueta, Roser Sala‐Llonch, Francesc Bosch, Raquel Perez‐Lopez, Pere Barba
Publikováno v:
eJHaem, Vol 4, Iss 4, Pp 1081-1088 (2023)
Abstract Chimeric antigen receptor (CAR) T‐cell therapy is a promising treatment option for relapsed or refractory (R/R) large B‐cell lymphoma (LBCL). However, only a subset of patients will present long‐term benefit. In this study, we explored
Externí odkaz:
https://doaj.org/article/462a685cd00d42bab3c5166896577a04
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/7a1f5ee0d59b4b8a8ea4f27f1a04e732
Autor:
Kinga Bernatowicz, Francesco Grussu, Marta Ligero, Alonso Garcia, Eric Delgado, Raquel Perez-Lopez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Tumor heterogeneity has been postulated as a hallmark of treatment resistance and a cure constraint in cancer patients. Conventional quantitative medical imaging (radiomics) can be extended to computing voxel-wise features and aggregating tu
Externí odkaz:
https://doaj.org/article/5b3a1112d8e04a3e9191a23fcc6fdbe4
Autor:
Alonso Garcia-Ruiz, Pablo Naval-Baudin, Marta Ligero, Albert Pons-Escoda, Jordi Bruna, Gerard Plans, Nahum Calvo, Monica Cos, Carles Majós, Raquel Perez-Lopez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Glioblastoma is the most common primary brain tumor. Standard therapy consists of maximum safe resection combined with adjuvant radiochemotherapy followed by chemotherapy with temozolomide, however prognosis is extremely poor. Assessment of
Externí odkaz:
https://doaj.org/article/8bd6ad5684ac4d938d88553a2be568f0
Publikováno v:
Frontiers in Psychology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/8f07847b39ca4cdab9109aa901bb4845
Autor:
Oliver Lukas, Sedlaczek, Jens, Kleesiek, Ferdia A, Gallagher, Jacob, Murray, Sebastian, Prinz, Raquel, Perez-Lopez, Evia, Sala, Caroline, Caramella, Sebastian, Diffetock, Nathalie, Lassau, Andrew N, Priest, Chikako, Suzuki, Roberto, Vargas, Tommaso, Giandini, Marta, Vaiani, Antonella, Messina, Lennart K, Blomqvist, Regina G H, Beets-Tan, Petra, Oberrauch, Heinz-Peter, Schlemmer, Michael, Bach
Publikováno v:
Scientia
Objectives In the Cancer Core Europe Consortium (CCE), standardized biomarkers are required for therapy monitoring oncologic multicenter clinical trials. Multiparametric functional MRI and particularly diffusion-weighted MRI offer evident advantages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d8b152f7906dc29dd9dec816a061dd2
https://doi.org/10.1007/s00330-022-08880-7
https://doi.org/10.1007/s00330-022-08880-7
Autor:
Johann S. de Bono, Suzanne Carreira, Arul M. Chinnaiyan, Emma Hall, Christopher J. Lord, Alexa Gillman, Diletta Bianchini, Nina Tunariu, Adam Sharp, Zafeiris Zafeiriou, Pasquale Rescigno, Semini Sumanasuriya, Ruth Riisnaes, Ines Figueiredo, Mateus Crespo, Matthew Clarke, Mark Atkin, Claudia Bertan, Gunther Boysen, Daniel Nava Rodrigues, George Seed, Penny Flohr, Berni Ebbs, Gemma Fowler, Shahneen Sandhu, Dan R. Robinson, David Dolling, Raquel Perez-Lopez, Susana Miranda, Nuria Porta, Helen Mossop, Wei Yuan, Joaquin Mateo, Jane Goodall
Plots showing percentage changes in total cfDNA concentration for each patient at weeks 4 and 8 of treatment, compared to same-patient baseline value. The left plot includes non-responding patients and the right plot includes patients who responded t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42ee078515e95060afc2ec08c429ee52
https://doi.org/10.1158/2159-8290.22531838.v1
https://doi.org/10.1158/2159-8290.22531838.v1
Autor:
Johann S. de Bono, Joaquin Mateo, Suzanne Carreira, Christopher E. Barbieri, Wei Yuan, Mark A. Rubin, Theresa MacDonald, Adam Sharp, Jane Goodall, Matthew Clarke, Mark Atkin, Flavia M. de Oliveira, Claudia Bertan, Sara Aziz, Veronica Gil, Rossitza Christova, Ana Ferreira, Inês Figueiredo, Susana Miranda, Nina Tunariu, Raquel Perez-Lopez, Deirdre Moloney, Joanne Hunt, Diletta Bianchini, Semini Sumanasuriya, Zafeiris Zafeiriou, Mateus Crespo, Ruth Riisnaes, David Dolling, George Seed, Pasquale Rescigno, Daniel N. Rodrigues, Gunther Boysen
Supplementary figure and table legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd5fa90176b766562a45870260587945
https://doi.org/10.1158/1078-0432.22470174
https://doi.org/10.1158/1078-0432.22470174